Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Exploring the multi-drug resistance (MDR) inhibition property of Sildenafil: phosphodiesterase 5 as a therapeutic target and a potential player in reversing MDR for a successful breast cancer treatment

2025AIMS Medical ScienceJournalOpen access

10.3934/medsci.2025010 Full text0 citations

Authors

4 authors across 5 institutions in 2 countries.

Anne A. AdeyanjuFirst author
- Lead City University (NG)
- University of Uyo (NG)
Wonderful B. Adebagbo
- McPherson University (NG)
Olorunfemi R. Molehin
- Ekiti State University (NG)
Omolola OyenihiSenior author
- Cape Peninsula University of Technology (ZA)
- Lead City University (NG)
- McPherson University (NG)
- University of Uyo (NG)
- Ekiti State University (NG)
as printed: Omolola R. Oyenihi

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Phosphodiesterase function and regulationlevel 3 · 1.00
Enzyme function and inhibitionlevel 3 · 0.96
Peptidase Inhibition and Analysislevel 3 · 0.96

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · AIMS Medical Science · 0 citations
https://openalex.org/W4409659186

Exploring the multi-drug resistance (MDR) inhibition property of Sildenafil: phosphodiesterase 5 as a therapeutic target and a potential player in reversing MDR for a successful breast cancer treatment · Sankore